Evidence map›Paper›PMID 33590505›Full record

ArticlePhotochemistry and photobiology2021

Impact of High Solar UV Radiant Exposures in Spring 2020 on SARS-CoV-2 Viral Inactivation in the UK

Rebecca Rendell, Marina Khazova, Michael Higlett, John O'Hagan

Abstract read
In one paragraph

Article in Photochemistry and photobiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Recent increases in solar UV radiation across Europe: a 40-location study to identify trend boundaries.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2026
    Article
  2. Filling data gaps in long-term solar UV monitoring by statistical imputation methods.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2024
    Article
  3. Article
  4. Article
  5. Survey of Home-Use UV Disinfection ProductsPhotochemistry and photobiology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Rebecca RendellCentre for Radiation, Chemicals and Environmental Hazards, Public Health England, Chilton, Didcot, Oxfordshire, UK.ORCID 0000-0002-0746-7194
Marina KhazovaCentre for Radiation, Chemicals and Environmental Hazards, Public Health England, Chilton, Didcot, Oxfordshire, UK.
Michael HiglettCentre for Radiation, Chemicals and Environmental Hazards, Public Health England, Chilton, Didcot, Oxfordshire, UK.
John O'HaganCentre for Radiation, Chemicals and Environmental Hazards, Public Health England, Chilton, Didcot, Oxfordshire, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Potential for SARS-CoV-2 viral inactivation by solar UV radiation in outdoor spaces in the UK has been assessed. Average erythema effective and UV-A daily radiant exposures per month were higher (statistically significant, P < 0.05) in spring 2020 in comparison with spring 2015-2019 across most of the UK, while irradiance generally appeared to be in the normal expected range of 2015-2019. It was found that these higher radiant exposures may have increased the potential for SARS-CoV-2 viral inactivation outdoors in April and May 2020. Assessment of the 6-year period 2015-2020 in the UK found that for 50-60% of the year, that is most of October to March, solar UV is unlikely to have a significant (at least 90% inactivation) impact on viral inactivation outdoors. Minimum times to reach 90% and 99% inactivation in the UK are of the order of tens of minutes and of the order of hours, respectively. However, these times are best case scenarios and should be treated with caution.

Indexed as

Ultraviolet RaysCOVID-19DisinfectionHumansRadiation ExposureSARS-CoV-2SunlightUnited KingdomVirus Inactivation

Identifiers

PMID33590505
PMCPMC8013580

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.